Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 20, 2019
Alexion and Affibody AB announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases.
read more
Wednesday, March 20, 2019
CherryCircle announced the appointment of Emma Cartmell to its board of directors.
read more
Wednesday, March 20, 2019
Pulse Biosciences announced the appointment of Mitchell Levinson to its board of directors.
read more
Wednesday, March 20, 2019
NJII has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.
read more
Wednesday, March 20, 2019
Merck KGaA, Darmstadt, Germany and Pfizer announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating avelumab in combination with chemotherapy.
read more
Wednesday, March 20, 2019
Merck and NGM announced Merck has exercised its option to extend the research phase of the companies’ collaboration for an additional two-year period to March 2022.
read more
STA Pharmaceutical announce a strategic partnership.
read more
Servier has entered into a collaborative study with Harvard University researchers to explore a new avenue for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).
read more
The agency expects many companies will be able to manufacture losartan without nitrosamine impurities and replenish the U.S. supply in approximately six months.
read more
Roche announced the CE-IVD mark and launch of NAVIFY Mutation Profiler.
read more
Thermo Fisher Scientific is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
read more
PCI Pharma Services (PCI) announced Serge Dupuis has been appointed as Senior Vice President and Chief Financial Officer.
read more
WuXi Biologics has received EMA GMP certificates for the production of Trogarzo™ at its cGMP DS and DP manufacturing facilities in Wuxi city and its cGMP cell banking facilities in Shanghai.
read more
Paragon Bioservices has announced the appointment of Thomas VanCott, Ph.D., as Chief Technology and Strategy Officer (CTSO), along with several key promotions and new hires.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more